Share-based Compensation (Tables)

3 Months Ended

Jun. 30, 2021

Summary of share-based compensation expense for options

The following table summarizes the share-based compensation expense for SSARs, restricted and performance grants included in the condensed consolidated statements of operations:

	Three Months Ended June 30,
(In thousands)	2021		2020
Product development	$	2,065	$	172
Sales and marketing		331		36
General and administrative		1,225		1,218
Total share-based compensation expense	$	3,621	$	1,426

Activity related SSARs award

The following table summarizes the activity during the three months ended June 30, 2021 for SSARs awarded under the 2020 and 2016 Plans:

	Number of Rights			Weighted-Average Exercise Price		Remaining Contractual Term		Aggregate Intrinsic Value
				(per right)		(in years)		(in thousands)
Outstanding at April 1, 2021		3,068,253		$	20.90
Exercised		(714,712	)		11.78
Forfeited		(15,818	)		20.02
Expired		(162	)		14.22
Outstanding at June 30, 2021		2,337,561		$	23.69		5.4	$	77,558
Exercisable at June 30, 2021		1,255,211		$	21.99		5.2	$	43,788
Vested and expected to vest at June 30, 2021		2,337,561		$	23.69		5.4	$	77,558

The following table summarizes the activity during the three months ended June 30, 2021 for restricted shares awarded under the 2020 and 2016 Plans:

	Number of Shares			Weighted-Average Grant-Date Fair Value
				(per share)
Outstanding at April 1, 2021		132,198		$	37.67
Granted		8,610			52.23
Forfeited		(2,072	)		24.39
Outstanding at June 30, 2021		138,736		$	38.77